Zydus Cadila has a wide ranging presence in formulations, Active Pharmaceutical Ingredients (API), diagnostics, health & dietetic foods, skin care and animal healthcare. In 1995, Cadila Laboratories emerged as Cadila Healthcare under the aegis of the Zydus group. Zydus Cadila markets several need based therapies through its core divisions: Zydus Cadila, Zydus Alidac, Zydus Medica, Zydus Biogen and speciality divisions Zydus Neurosciences and Zydus Vaccicare. Company also operates in international market through its subsidiaries: Zydus Healthcare, Zydus Pharmaceuticals (USA), Zydus France and Zydus Healthcare Brasil. The company has also set up a new division called Zyfine Chemicals with focus on custom synthesis products.

Acquired Companies: Nikkho, Etna Biotech S.r.l., Biochem Pharmaceutical Industries Ltd.